Dimiracetam in Painful Neuropathies Affecting AIDS Patients

PHASE2UnknownINTERVENTIONAL

Enrollment

244

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Acquired Immunodeficiency Syndrome

Interventions

DRUG

Dimiracetam

Capsules for oral administration twice daily

DRUG

Dimiracetam 25 mg

Inactive dose level in capsules administered orally twice daily

Trial Locations (1)

Neurotune AG, Lugano